Actively growing sugarbeet is treated with the post-emergent herbicide phenmedipham at times when ozone pollution episodes are likely to occur. There is a possibility of an interaction occurring between ozone and phenmedipham as both treatments produce similar effects in susceptible plants, such as a reduction in growth and photosynthesis and an increase in the activities of endogenous antioxidant enzymes. To investigate this likelihood, laboratory experiments were conducted in which two-to three-leaf sugarbeet plants (Beta vulgaris L. cv. Saxon) were exposed to a simulated two-day ozone episode (100 nl litre-'. 7 h day-I ) followed three days later by treatment with field rate phenmedipham (1.14 kg A1 ha-'). Growth analysis indicated that an interaction was occurring in which plants treated with ozone and phenmedipham had less reduction in shoot fresh weight than expected. Exposure to phenmedipham alone or ozone followed by phenmedipham reduced net photosynthesis by over 50% and transpiration rate by 30%. The activities of antioxidant enzymes such as catalase, guaiacol peroxidase and superoxide dismutase were stimulated by both treatments individually, but to a greater extent when ozone and phenmedipham were combined. For example, three days after herbicide treatment, the activity of superoxide dismutase increased by 20% in plants treated with ozone alone, 20% in plants treated with phenmedipham alone and 85% in plants that were treated with ozone followed by phenmedipham. We conclude that ozone pollution may predispose sugarbeet to tolerate the herbicide phenmedipham by enhancing the activity of the endogenous antioxidant detoxification enzyme system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.